The healthcare diagnostics specialist exceeded top- and bottom-line expectations despite a slight revenue drop.
The Marin County developer of treatments for rare diseases noted that its treatment for a form of rickets has been driving ...
Hosted on MSN3h
Dillard's Q3 Earnings Coming Up: Here's What You Should KnowDillard’s, Inc. DDS is expected to register year-over-year top and bottom-line declines when it reports third-quarter fiscal ...
Operator Good morning, and welcome to Icahn Enterprises LP third-quarter 2024 earnings call with Andrew Teno, president and ...
Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...
Toast Q3 earnings beat expectations with $1.30B in sales and 7,000 new locations added. Toast, Inc. TOST shares are trading ...
Paramount’s direct to consumer division swung to a profit of $49 million during the third quarter of 2024 – its second ...
The Fund returned 5.33%, reflecting performance at the net asset value of Class I shares with all distributions reinvested, ...
Morgan Stanley analyst Erin Wright has maintained their bullish stance on XRAY stock, giving a Buy rating yesterday. Erin Wright has given his ...
PE dealmaking in healthcare services has declined since 2021 highs, according to PitchBook. Firms began to pull back their ...
Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...
B2Gold Corp. ( (BTG) ) has released its Q3 earnings. Here is a breakdown of the information B2Gold Corp. presented to its investors. B2Gold ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback